The NM_000018.4 c.507_527del (p.Met169_Gly175del) variant in ACADVL is an in-frame deletion (removes amino acids Met169_Gly175) in exon7/20 that is not predicted to impact splicing (SpliceAI: 0.0200). The highest population minor allele frequency in gnomAD v4.0.0 is 0.0001 in Middle Eastern population, which is lower than the ClinGen ACADVL Variant Curation Expert Panel threshold (<0.001) for PM2_Supporting, meeting this criterion (PM2_Supporting). The c.507_527del variant is predicted to cause a change in the length of the protein (p. Met169_Gly175del) due to an in-frame deletion of seven amino acids in a non-repeat region (PM4). This variant is reported in the literature in two individuals affected with very long-chain acyl-CoA dehydrogenase deficiency in a heterozygous fashion, who displayed elevated C14:1 carnitine level (0.8 and 1.14 µmol/L, respectively) during newborn screening and reduced VLCAD enzyme levels in the latter one of them, which is highly specific for VLCAD deficiency (PP4_Moderate, PMID: 31031081). Due to limited evidence, this variant is classified as a variant of uncertain significance for autosomal recessive very long chain acyl-CoA dehydrogenase (VLCAD) deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: PM2_Supporting, PM4, PP4_Moderate (ACADVL VCEP specifications version 1; approved November 9, 2021).